 |
|
|
|
|
|
Previous 25 Showing Treatment 26 to 50 of 190 Next 25 |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Dallas, TX USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Tampa, FL USA |
|
03/15/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Summit, NJ USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Cleveland, OH USA |
|
03/15/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Los Angeles, CA USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Columbus, OH USA |
|
03/15/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Chicago, IL USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Ann Arbor, MI USA |
|
03/15/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Minneapolis, MN USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Rochester, NY USA |
|
03/15/2009 |
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Durham, NC USA |
|
03/04/2009 |
|
|
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
New York, NY USA |
|
03/04/2009 |
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Tampa, FL USA |
|
03/04/2009 |
|
|
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Los Angeles, CA USA |
|
03/04/2009 |
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Omaha, NE USA |
|
03/04/2009 |
|
|
|
|
|
Details |
|
A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 (MAb-425) in High Grade Gliomas |
|
Philadelphia, PA USA |
|
02/12/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Chicago, IL USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Detroit, MI USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Los Angeles, CA USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Durham, NC USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
San Francisco, CA USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Charlottesville, VA USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Cleveland, OH USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Cleveland, OH USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Hackensack, NJ USA |
|
01/31/2009 |
|
|
|
|
|
